Pricing Log in Create free account
Saturday 17 October 2026 Export ABT’s income statement to Excel — free account

Abbott Laboratories

ABT Healthcare Medical Devices

Abbott Laboratories' revenue for fiscal 2025 (year ended December 2025) was $44.3 billion, up 5.67% from fiscal 2024. In the quarter to June 2026, revenue grew 13.0%, EPS fell 47.5%, free cash flow grew 28.9% and total debt rose 142.7%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years; insiders bought in the last twelve months.

104.88 0.20 +0.19%
Market cap
$181.1B
P/E
33.9×
Fwd P/E
22.9×
Dividend yield
2.40%
F-score
5/9
Altman Z
5.61
Beneish M
−2.50
Dividend safety
62/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Abbott Laboratories (ABT) P/S ratio

Alert me on P/S ratio

As of 16 October 2026, Abbott Laboratories (ABT) trades at a P/S ratio of 3.9×. Over the past ten years it has ranged from 2.7× (February 2016) to 6.6× (February 2021); the current reading is higher than 35% of that period. That is above the Medical Devices industry median of 2.3× and above the Healthcare sector median of 3.4×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 4.9× 4.89%
FY2024 4.7× (1.55%)
FY2023 4.8× 8.29%
FY2022 4.4× (24.12%)
FY2021 5.8× 3.39%
FY2020 5.6× 16.53%
FY2019 4.8× 15.75%
FY2018 4.2× 11.34%
FY2017 3.7× 35.03%
FY2016 2.8× (16.00%)

Quarterly newest first

Period P/S ratio Change
Jun 2026 3.4× (14.47%)
Mar 2026 4.0× (19.45%)
Dec 2025 4.9× (7.54%)
Sep 2025 5.3× (3.24%)
42 more quarters

Against its own ten years

Low 2.7× High 6.6×
Ten-year median 4.4×
Current reading's percentile 29

P/S ratio against peers

Company P/S ratio
PHG Koninklijke Philips N.V. compare 1.2×
GEHC GE HealthCare Technologies Inc. compare 1.5×
BSX Boston Scientific Corporation compare 3.1×
MDT Medtronic PLC compare 3.2×
STE STERIS plc compare 3.6×
ABT Abbott Laboratories 3.9×
SYK Stryker Corporation compare 4.4×
DXCM DexCom, Inc. compare 6.6×
EW Edwards Lifesciences Corporation compare 7.7×
Medical Devices industry median 2.3×
Healthcare sector median 3.4×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on ABT